Porcine reproductive and respiratory syndrome vaccine
US5976537A · kind A · utility
32Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 1996 |
| Grant date | Nov 2, 1999 |
| Priority date | — |
| Expiry date | Jul 2, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/815
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Vaccines against porcine reproductive and respiratory syndrome (PRRS) have been produced by attenuation of wild type strains of the virus selected from the group of attenuated NADC-8, attenuated NADC-9 and attenuated NVSL-14. These vaccines are useful in monovalent, bivalent or polyvalent vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.